These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20087671)

  • 21. [Nosocomial hepatitis B virus, hepatitis C virus and HIV infections by infectious medial personnel].
    Hasselhorn HM; Hofmann F
    Gesundheitswesen; 1998 Oct; 60(10):545-51. PubMed ID: 9844287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of backward bifurcation in a model of hepatitis B and C viruses.
    Qesmi R; Wu J; Wu J; Heffernan JM
    Math Biosci; 2010 Apr; 224(2):118-25. PubMed ID: 20085774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global threshold dynamics in an HIV virus model with nonlinear infection rate and distributed invasion and production delays.
    Yuan Z; Zou X
    Math Biosci Eng; 2013 Apr; 10(2):483-98. PubMed ID: 23458310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mathematical treatment of AIDS and condom use.
    Greenhalgh D; Doyle M; Lewis F
    IMA J Math Appl Med Biol; 2001 Sep; 18(3):225-62. PubMed ID: 11817744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global asymptotic properties of virus dynamics models with dose-dependent parasite reproduction and virulence and non-linear incidence rate.
    Korobeinikov A
    Math Med Biol; 2009 Sep; 26(3):225-39. PubMed ID: 19299417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
    Tripathi AK; Khanna M; Gupta N; Chandra M
    J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global stability for epidemic model with constant latency and infectious periods.
    Huang G; Beretta E; Takeuchi Y
    Math Biosci Eng; 2012 Apr; 9(2):297-312. PubMed ID: 22901066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global stability of an age-structured virus dynamics model with Beddington-DeAngelis infection function.
    Yang Y; Ruan S; Xiao D
    Math Biosci Eng; 2015 Aug; 12(4):859-77. PubMed ID: 25974337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global properties of a delayed SIR epidemic model with multiple parallel infectious stages.
    Wang X; Liu S
    Math Biosci Eng; 2012 Jul; 9(3):685-95. PubMed ID: 22881032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The serologic study on the blood transmission origin of HIV].
    Zhu B; Wu N; Qiang L; Shao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):140-2. PubMed ID: 11860777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An HBV model with diffusion and time delay.
    Xu R; Ma Z
    J Theor Biol; 2009 Apr; 257(3):499-509. PubMed ID: 19174169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global stability for a class of HIV virus-to-cell dynamical model with Beddington-DeAngelis functional response and distributed time delay.
    Zhou XR; Zhang L; Zheng T; Li HL; Teng ZD
    Math Biosci Eng; 2020 Jun; 17(5):4527-4543. PubMed ID: 33120517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability and bifurcations in an epidemic model with varying immunity period.
    Blyuss KB; Kyrychko YN
    Bull Math Biol; 2010 Feb; 72(2):490-505. PubMed ID: 19898905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of heterogeneity on the dynamics of an SEIR epidemic model.
    Shuai Z; van den Driessche P
    Math Biosci Eng; 2012 Apr; 9(2):393-411. PubMed ID: 22901070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.